awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34650664-D3FAAA33-130A-4D32-AC44-0434FC8128FC
Q34650664-D3FAAA33-130A-4D32-AC44-0434FC8128FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34650664-D3FAAA33-130A-4D32-AC44-0434FC8128FC
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial.
P921
Q34650664-D3FAAA33-130A-4D32-AC44-0434FC8128FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34650664-D3FAAA33-130A-4D32-AC44-0434FC8128FC
rank
NormalRank
type
BestRank
Statement
P921
phase III clinical trial